IONS
#914
Ionis Pharmaceuticals, Inc. - Common Stock
60.3 6 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.13%
Variación mensual
+14.62%
Variación en los últimos 6 meses
-24.05%
Cambio anual
-16.31%
Cierres anteriores
61.0 5
Open
60.3 6
Mínimo
60.3 6
Máximo
60.3 6
Volumen
188
Financials
- Market Capitalization 10.03 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-68.35
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 875 |  KRYS Krystal Biotech, Inc. - Common Stock | 359.36 USD | +2.25% | +4.52% | +12.05% | +92.04% | 10.64 B USD | ||
| 889 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 198.52 USD | -0.25% | -4.36% | -7.88% | +52.47% | 10.40 B USD | ||
| 916 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.63 USD | +0.70% | -0.92% | +6.41% | +98.34% | 10.00 B USD | ||
| 919 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.81 USD | +0.56% | -3.12% | +15.61% | +101.03% | 9.88 B USD |